US 11498966
PD-1 and PD-L1 binding agents
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 11498966 (PD-1 and PD-L1 binding agents) held by Orionis Biosciences, Inc expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Orionis Biosciences, Inc
- Grant date
- Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61P, A61P35/00